Regarding potential mechanisms underlying the observed associations, it has been suggested that hypothalamic dysfunction may be an important driver of weight loss in preclinical AD, since Aβ and tau deposits have been described in AD in this nucleus, which plays a key role in energy homeostasis [14]. The gene discussed is MAPT; the disease is Alzheimer disease.